{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:17:05Z","timestamp":1768551425946,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to develop a Thai version of the Dry Eye\u2013Related Quality-of-Life Score (DEQS-Th) questionnaire and evaluate its validity, reliability, and feasibility among Thai participants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The DEQS-Th, a 15-item self-report measuring dry eye and its impact on quality of life (QOL) was developed based on the DEQS. The questionnaire was divided into two subscales: <jats:italic>Bothersome Ocular Symptoms<\/jats:italic> (six questions), and <jats:italic>Impact on Daily Life<\/jats:italic> (nine questions). It employed a 5-point Likert scale, addressing on both the frequency and the degree of symptoms. Backward and forward and cultural adaptation process translation methods were employed. Thirty healthy participants were enrolled to evaluate the feasibility of the DEQS-Th in terms of difficulty and convenience. Reliability was assessed using internal consistency determined by Cronbach\u2019s alpha, with values &gt;\u20090.7 considered acceptable. Convergent validity was determined by the correlation between DEQS-Th and overall health status. Confirmatory factor analysis was conducted for its factor structure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The participants\u2019 mean age was 38.6\u2009\u00b1\u200912.9\u2009years, and 23 (76.7%) were females. The mean time to complete the questionnaire was 9.3\u2009\u00b1\u20092.7\u2009min. The Cronbach\u2019s alpha of the ocular symptoms subscale, impact on QOL subscale, and summary score on frequency and degree were 0.80 and 0.70, 0.89 and 0.89, and 0.90 and 0.89, respectively. The overall health status significantly correlated with the summary score (<jats:italic>r<\/jats:italic>\u2009=\u20090.564, <jats:italic>p<\/jats:italic>\u2009=\u2009.001), subscale ocular symptoms (<jats:italic>r<\/jats:italic>\u2009=\u20090.594, <jats:italic>p<\/jats:italic>\u2009=\u2009.001), and impact on QOL scores (<jats:italic>r<\/jats:italic>\u2009=\u20090.626, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001) of the DEQS-Th, respectively. A one-factor model fitted the data the best for both the ocular symptoms subscale (CFI\u2009=\u20091.000, TLI\u2009=\u20091.000, RMSEA\u2009=\u20090.000) and the impact on QOL subscale (CFI\u2009=\u20090.998, TLI\u2009=\u20090.997, RMSEA\u2009=\u20090.053).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>When tested among normal participants, the DEQS-Th is a valid and reliable measurement for dry eye symptoms and impact on QOL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-02077-0","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T08:02:46Z","timestamp":1630137766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thai version of the dry eye-related quality-of-life score questionnaire: preliminary assessment for psychometric properties"],"prefix":"10.1186","volume":"21","author":[{"given":"Sasiwimon","family":"Tansanguan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napaporn","family":"Tananuvat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahathai","family":"Wongpakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinakon","family":"Wongpakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somsanguan","family":"Ausayakhun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"key":"2077_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017;15:802\u201312.","journal-title":"Ocul Surf"},{"key":"2077_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15:334\u201365.","journal-title":"Ocul Surf"},{"key":"2077_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1542-0124(12)70040-X","volume":"4","author":"KK Nichols","year":"2006","unstructured":"Nichols KK. Patient-reported symptoms in dry eye disease. Ocul Surf. 2006;4:137\u201345.","journal-title":"Ocul Surf"},{"key":"2077_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jtos.2012.01.007","volume":"10","author":"I Guillemin","year":"2012","unstructured":"Guillemin I, Begley C, Chalmers R, Baudouin C, Arnould B. Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: revisiting the standards. Ocul Surf. 2012;10:84\u201399.","journal-title":"Ocul Surf"},{"key":"2077_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","volume":"1","author":"M Uchino","year":"2013","unstructured":"Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013;1:51\u20137.","journal-title":"Curr Ophthalmol Rep"},{"key":"2077_CR6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","volume":"110","author":"RM Schiffman","year":"2003","unstructured":"Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412\u20139.","journal-title":"Ophthalmology"},{"key":"2077_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1542-0124(12)70043-5","volume":"4","author":"P Buchholz","year":"2006","unstructured":"Buchholz P, Steeds CS, Stern LS, Wiederkehr DP, Doyle JJ, Katz LM, et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf. 2006;4:155\u201361.","journal-title":"Ocul Surf"},{"key":"2077_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1477-7525-9-111","volume":"9","author":"L Abetz","year":"2011","unstructured":"Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes. 2011;9:111.","journal-title":"Health Qual Life Outcomes"},{"key":"2077_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/ICO.0000000000000038","volume":"33","author":"JR Grubbs Jr","year":"2014","unstructured":"Grubbs JR Jr, Tolleson-Rinehart S, Huynh K, Davis RM. A review of quality of life measures in dry eye questionnaires. Cornea. 2014;33:215\u20138.","journal-title":"Cornea"},{"key":"2077_CR10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jamaophthalmol.2013.4503","volume":"131","author":"Y Sakane","year":"2013","unstructured":"Sakane Y, Yamaguchi M, Yokoi N, Uchino M, Dogru M, Oishi T, et al. Development and validation of the dry eye-related quality-of-life score questionnaire. JAMA Ophthalmol. 2013;131:1331\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"2077_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/diagnostics10080559","volume":"10","author":"Y Okumura","year":"2020","unstructured":"Okumura Y, Inomata T, Iwata N, Sung J, Fujimoto K, Fujio K, et al. A review of dry eye questionnaires: measuring patient-reported outcomes and health-related quality of life. Diagnostics. 2020;10(8):559.","journal-title":"Diagnostics"},{"issue":"11","key":"2077_CR12","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/ICO.0000000000000243","volume":"33","author":"J Grubbs Jr","year":"2014","unstructured":"Grubbs J Jr, Huynh K, Tolleson-Rinehart S, Weaver MA, Williamson J, Lefebvre C, et al. Instrument development of the UNC dry eye management scale. Cornea. 2014;33(11):1186\u201392.","journal-title":"Cornea"},{"issue":"1","key":"2077_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12955-017-0718-5","volume":"15","author":"B Zheng","year":"2017","unstructured":"Zheng B, Liu XJ, Sun YF, Su JZ, Zhao Y, Xie Z, et al. Development and validation of the Chinese version of dry eye related quality of life scale. Health Qual Life Outcomes. 2017;15(1):145.","journal-title":"Health Qual Life Outcomes"},{"key":"2077_CR14","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/01.ico.0000244875.92879.1a","volume":"25","author":"K Lekhanont","year":"2006","unstructured":"Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea. 2006;25:1162\u20137.","journal-title":"Cornea"},{"key":"2077_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94\u2013104.","journal-title":"Value Health"},{"key":"2077_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3758\/s13428-015-0619-7","volume":"48","author":"CH Li","year":"2016","unstructured":"Li CH. Confirmatory factor analysis with ordinal data: comparing robust maximum likelihood and diagonally weighted least squares. Behav Res Methods. 2016;48:936\u201349.","journal-title":"Behav Res Methods"},{"key":"2077_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"LT Hu","year":"1999","unstructured":"Hu LT, Bentler PM. Cut off criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6:1\u201355.","journal-title":"Struct Equ Model"},{"key":"2077_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/0049124192021002005","volume":"21","author":"MW Browne","year":"1992","unstructured":"Browne MW, Cudeck R. Alternative ways of assessing model fit. Socio Methods Res. 1992;21:230\u201358.","journal-title":"Socio Methods Res"},{"key":"2077_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1207\/s15327574ijt0502_4","volume":"5","author":"DJ Mundfrom","year":"2005","unstructured":"Mundfrom DJ, Shaw DG, Ke TL. Minimum sample size recommendations for conducting factor analyses. Inter J Test. 2005;5:159\u201368.","journal-title":"Inter J Test"},{"key":"2077_CR20","doi-asserted-by":"publisher","first-page":"e033940","DOI":"10.1136\/bmjopen-2019-033940","volume":"9","author":"A Midorikawa-Inomata","year":"2019","unstructured":"Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, et al. Reliability and validity of the Japanese version of the ocular surface disease index for dry eye disease. BMJ Open. 2019;9:e033940.","journal-title":"BMJ Open"},{"key":"2077_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615\u201321.","journal-title":"Arch Ophthalmol"},{"key":"2077_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/diagnostics10040203","volume":"10","author":"T Inomata","year":"2020","unstructured":"Inomata T, Nakamura M, Iwagami M, Midorikawa-Inomata A, Okumura Y, Fujimoto K, et al. Comparing the Japanese version of the ocular surface disease index and dry eye-related quality-of-life score for dry eye symptom assessment. Diagnostics. 2020;10:203.","journal-title":"Diagnostics"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02077-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02077-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02077-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T20:04:22Z","timestamp":1630181062000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02077-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02077-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved from the Research and Ethics Committee of the Faculty of Medicine, Chiang Mai University (Study code: 010\u20132562) and followed the tenets of Declaration of Helsinki. Written informed consent was obtained from all the participants after complete explanation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}